Literature DB >> 15013969

Depressed type 1 cytokine synthesis by superantigen-activated CD4+ T cells of women with human papillomavirus-related high-grade squamous intraepithelial lesions.

Bang-Ning Lee1, Michele Follen, De-Yu Shen, Anais Malpica, Karen Adler-Storthz, William T Shearer, James M Reuben.   

Abstract

Carcinoma of the cervix is causally related to infection with the human papillomavirus (HPV), and T cells play a pivotal role in the immune response of the host to rid itself of HPV infection. Therefore, we assessed the T-cell function of women with HPV-related cervical neoplasia against a superantigen, Staphylococcus enterotoxin B (SEB). Each woman provided a cervical brush specimen for HPV DNA testing and Papanicolaou (Pap) smears for the staging of cervical lesions. They also provided a blood specimen for determination of the ability of CD4(+) T and CD8(+) T cells to synthesize Th1 (interleukin-2 [IL-2], gamma interferon [IFN-gamma], and tumor necrosis factor alpha [TNF-alpha]) and Th2 (IL-10) cytokines in response to activation with SEB. Compared with control subjects with self-attested negative Pap smears, women with high-grade squamous intraepithelial lesions (HSIL) had significantly lower percentages of activated CD4(+) T cells that produced IL-2 (P = 0.045), IFN-gamma (P = 0.040), and TNF-alpha (P = 0.015) and a significantly lower percentage of activated CD8(+) T cells that produced IL-2 (P < 0.01). These data indicate that women with HPV-related cervical HSIL show a decrease in Th1 cytokine production by activated CD4(+) T cells and suggested that compromised T-helper functions may negatively impact the function of cytotoxic CD8(+) T cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15013969      PMCID: PMC371191          DOI: 10.1128/cdli.11.2.239-244.2004

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  25 in total

1.  Distinct thresholds for CD8 T cell activation lead to functional heterogeneity: CD8 T cell priming can occur independently of cell division.

Authors:  Nathalie Auphan-Anezin; Grégory Verdeil; Anne-Marie Schmitt-Verhulst
Journal:  J Immunol       Date:  2003-03-01       Impact factor: 5.422

2.  Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females.

Authors:  A B Moscicki; N Hills; S Shiboski; K Powell; N Jay; E Hanson; S Miller; L Clayton; S Farhat; J Broering; T Darragh; J Palefsky
Journal:  JAMA       Date:  2001-06-20       Impact factor: 56.272

3.  Single-cell cytokine analysis allows detection of cervical T-cell responses against human papillomavirus type 16 L1 in women infected with genital HPV.

Authors:  Jo-Ann S Passmore; Vanessa C Burch; Enid G Shephard; Dianne J Marais; Bruce Allan; Patti Kay; Robert C Rose; Anna-Lise Williamson
Journal:  J Med Virol       Date:  2002-06       Impact factor: 2.327

Review 4.  Approaches to improve engineered vaccines for human immunodeficiency virus and other viruses that cause chronic infections.

Authors:  J A Berzofsky; J D Ahlers; M A Derby; C D Pendleton; T Arichi; I M Belyakov
Journal:  Immunol Rev       Date:  1999-08       Impact factor: 12.988

5.  Application of Staphylococcal enterotoxin B on normal and atopic skin induces up-regulation of T cells by a superantigen-mediated mechanism.

Authors:  L Skov; J V Olsen; R Giorno; P M Schlievert; O Baadsgaard; D Y Leung
Journal:  J Allergy Clin Immunol       Date:  2000-04       Impact factor: 10.793

6.  Synthesis of IFN-gamma by CD8(+) T cells is preserved in HIV-infected women with HPV-related cervical squamous intraepithelial lesions.

Authors:  B N Lee; M Follen; G Tortolero-Luna; N Eriksen; A Helfgott; H Hammill; W T Shearer; J M Reuben
Journal:  Gynecol Oncol       Date:  1999-12       Impact factor: 5.482

7.  Antigen-driven T-cell selection in patients with cervical cancer as evidenced by T-cell receptor analysis and recognition of autologous tumor.

Authors:  H Pilch; H Höhn; C Neukirch; K Freitag; P G Knapstein; B Tanner; M J Maeurer
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

Review 8.  Human papillomavirus update with a particular focus on cervical disease.

Authors:  Suzanne M Garland
Journal:  Pathology       Date:  2002-06       Impact factor: 5.306

9.  Regulation of the IL-10 production by human T cells.

Authors:  K Rafiq; L Charitidou; D M Bullens; A Kasran; K Lorré; J Ceuppens; S W van Gool
Journal:  Scand J Immunol       Date:  2001-02       Impact factor: 3.487

10.  Early steps of lymphocyte activation bypassed by synergy between calcium ionophores and phorbol ester.

Authors:  A Truneh; F Albert; P Golstein; A M Schmitt-Verhulst
Journal:  Nature       Date:  1985 Jan 24-30       Impact factor: 49.962

View more
  6 in total

1.  Associations of cytokines, sleep patterns, and neurocognitive function in youth with HIV infection.

Authors:  Samuel B Foster; Ming Lu; Daniel G Glaze; James M Reuben; Lynnette L Harris; Evan N Cohen; Bang-Ning Lee; Enxu Zhao; Mary E Paul; Heidi Schwarzwald; Chivon McMullen-Jackson; Charla Clark; F Daniel Armstrong; Pim Y Brouwers; Tracie L Miller; Andrew A Colin; Gwendolyn B Scott; Shahriar Shahzeidi; Elizabeth J Willen; Deshratn Asthana; Steven E Lipshultz; Bruce W Thompson; William T Shearer
Journal:  Clin Immunol       Date:  2012-05-02       Impact factor: 3.969

2.  Loss of Keratin 17 induces tissue-specific cytokine polarization and cellular differentiation in HPV16-driven cervical tumorigenesis in vivo.

Authors:  R P Hobbs; A S Batazzi; M C Han; P A Coulombe
Journal:  Oncogene       Date:  2016-04-11       Impact factor: 9.867

3.  Peripheral blood lymphocytes from low-grade squamous intraepithelial lesions patients recognize vaccine antigens in the presence of activated dendritic cells, and produced high levels of CD8 + IFNγ + T cells and low levels of IL-2 when induced to proliferate.

Authors:  Jorge Hernández-Montes; Leticia Rocha-Zavaleta; Alberto Monroy-García; Benny Weiss-Steider; María Del Carmen Zaragoza-Ortega; Fernando Cruz-Talonia; Omar Cruz Y Cruz; Laura Bonifaz-Alfonso; Adriana Karina Chávez-Rueda; Martha Patricia Rojo-Aguilar; María Victoria Legorreta-Haquet; María de Lourdes Mora-García
Journal:  Infect Agent Cancer       Date:  2012-05-29       Impact factor: 2.965

4.  Development of biomarker panel to predict, prevent and create treatments tailored to the persons with human papillomavirus-induced cervical precancerous lesions.

Authors:  Liudmyla M Lazarenko; Olena E Nikitina; Evgen V Nikitin; Olga M Demchenko; Galyna V Kovtonyuk; Larysa O Ganova; Rostyslav V Bubnov; Veronika O Shevchuk; Natalia M Nastradina; Viktoria V Bila; Mykola Ya Spivak
Journal:  EPMA J       Date:  2014-01-06       Impact factor: 6.543

5.  Cytokine release in HR-HPV(+) women without and with cervical dysplasia (CIN II and III) or carcinoma, compared with HR-HPV(-) controls.

Authors:  Aagje G Bais; Ilse Beckmann; Patricia C Ewing; Marinus J C Eijkemans; Chris J L M Meijer; Peter J F Snijders; Theo J M Helmerhorst
Journal:  Mediators Inflamm       Date:  2007       Impact factor: 4.711

6.  Helper T lymphocyte response in the peripheral blood of patients with intraepithelial neoplasia submitted to immunotherapy with pegylated interferon-α.

Authors:  Márcia Antoniazi Michelin; Letícia Montes; Rosekeila Simões Nomelini; Marco Aurélio Trovó; Eddie Fernando Candido Murta
Journal:  Int J Mol Sci       Date:  2015-03-10       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.